VRTX is Vertex Pharmaceuticals Incorporated (Healthcare) — a non-dividend-paying stock. Trading at $556.75. Market cap: $138.81B. Capital Quality Rank: 99/100 — Market alpha.
Stock snapshot
| Price | $556.75 |
| Market cap | $138.81B |
| Sector | Healthcare |
| Exchange | NMS |
| Pays dividend | No |
Capital Quality & fundamentals
DiviDrip's Capital Analytics engine ranks every non-dividend stock 1-100 on a 4-factor composite (Shareholder Yield 30%, Cash-Flow ROI 25%, Operating Momentum 25%, Tail-Risk 20%) — sector-neutralized so a biotech isn't penalized for negative earnings the way a utility would be.
| Capital Quality Rank (1-100) | 99 / 100 · Market alpha |
| ROIC (TTM) | 24.3% |
| Revenue CAGR (3y) | 10.3% |
| Shareholder buyback yield | -0.04% |
| Altman Z-score zone | Safe |
About VRTX
Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta/Kaftrio, and Alyftrek for cystic fibrosis, where Vertex therapies remain the standard of care globally. Vertex has diversified its portfolio through Casgevy, a gene-editing therapy for beta thalassemia and sickle-cell disease, and Journavx, a non-opioid pain medication approved for the treatment of moderate-to-severe acute pain in adults. Additionally, Vertex is evaluating small-molecule inhibitors of APOL1-mediated kidney diseases. Vertex is also investigating cell therapies to deliver a potential functional cure for type 1 diabetes.
Related non-dividend companies
Other non-dividend stocks investors research alongside VRTX. Peer set from Massive news + returns similarity, filtered to names we currently track.
Frequently asked
What is VRTX's current stock price?
VRTX (Vertex Pharmaceuticals Incorporated) is currently trading at $556.75.
Does VRTX pay a dividend?
VRTX (Vertex Pharmaceuticals Incorporated) does not currently pay a regular dividend.
What is VRTX's Capital Quality Rank?
VRTX has a Capital Quality Rank of 99/100 — Market alpha. This score blends ROIC, revenue growth, buybacks, and balance-sheet health.
Track VRTX in DiviDrip
Add VRTX to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.
- Open DiviDrip — search VRTX and add it to your watchlist.
- Stock Screener — filter by sector, market cap, and Capital Quality Rank.
- How to use the Screener — sector / quality / market-cap filters explained.
Data refreshed 2026-09-02. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.